CHICAGO, July 3, 2024 /PRNewswire/ -- The
global Specialty Enzymes Market size is
estimated to be valued at USD 6.1
billion in 2024 and is projected to reach USD 9.2 billion by 2029, recording a CAGR of 8.5%
from 2024 to 2029 according to a report published by
MarketsandMarkets™. The biopharmaceutical industry's rapid
expansion, fueled by innovations in biotechnology and personalized
medicine, offers significant growth opportunities for the specialty
enzymes market. Enzymes are crucial in various biopharmaceutical
manufacturing stages, such as protein expression, purification, and
modification. They play a vital role in developing biologics,
including monoclonal antibodies, vaccines, and gene therapies. With
an aging population and a rising incidence of chronic diseases, the
demand for biopharmaceuticals is increasing, consequently driving
the need for enzymes in biopharmaceutical production.
Download PDF
Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=21682828
Browse in-depth TOC on "Specialty Enzymes Market"
297 – Tables
70 – Figures
306 –
Pages
Advancements in enzyme engineering have enabled the discovery of
new enzymes from natural sources, ensuring their safety and
efficacy in various applications. This includes their use in
producing specialty pharmaceuticals and in biocatalytic processes.
A recent study by the University of Notre
Dame researchers in January
2022 emphasized biocatalytic depolymerization as an
efficient and sustainable method for plastic treatment, addressing
environmental concerns and enhancing recycling efforts.
Additionally, the Manchester Institute of Biotechnology (MIB) has
developed an enzyme engineering platform to improve plastic
degradation using directed evolution techniques. These advancements
in genetic engineering and enzyme engineering for sustainable
practices highlight the specialty enzymes market's growth
potential, especially in addressing environmental issues and
promoting eco-friendly solutions.
Protease segment is identified to be the fastest growing
among the various types of enzymes during the forecast
period.
Proteases' rapid growth is crucial in the pharmaceutical
industry, where they are used in drug formulation and development.
Proteases facilitate the synthesis of therapeutic proteins and
peptides, which are essential for treating diseases like cancer,
diabetes, and autoimmune disorders. Additionally,
proteases are widely utilized in the biotechnology sector for
protein engineering and modification. They enable precise cleavage
and modification of proteins, which is fundamental in developing
novel biopharmaceuticals and conducting advanced research. The
increasing investment in biotechnology research and development
significantly contributes to the growing demand for proteases. For
example, the use of proteases in the production of insulin, a
critical drug for diabetes management, showcases their importance.
Companies like Novo Nordisk leverage proteases to enhance the
efficiency and yield of insulin production, ensuring a reliable
supply to meet the rising global demand.
Enzymes sourced from animals hold a significant share in the
specialty enzymes market
Animal-derived enzymes are often preferred for their high
specificity and efficiency in catalyzing biochemical reactions,
which is essential in various specialized processes. Pancreatic
enzymes, such as trypsin and chymotrypsin, are extensively used in
drug formulation and the production of biologics. These enzymes
help in the precise cleavage of peptide bonds, which is crucial for
the development and manufacturing of therapeutic proteins and
peptides. The specificity and activity levels of these enzymes make
them indispensable in pharmaceutical applications, contributing
significantly to their market share.
Additionally, animal-derived enzymes are essential in clinical
diagnostics. Enzymes like rennet, obtained from the stomachs of
calves, are used in the coagulation process in
cheese production, showcasing their importance in the food
industry. However, in clinical settings, enzymes like lactase,
derived from animal sources, are used in diagnostic kits to test
for lactose intolerance. This demonstrates their versatility and
utility in both food processing and medical diagnostics. The
significance of animal-sourced enzymes is the use of thrombin,
derived from bovine sources, in surgical procedures. Thrombin is
crucial for promoting blood clotting and is used in topical
hemostatic agents to control bleeding during surgeries. The high
efficacy and reliability of thrombin in medical applications
underscore the importance of animal-derived enzymes in the
specialty enzymes market.
Request Sample
Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=21682828
North America region to
dominate the specialty enzymes market during the forecast
period.
North America holds the highest
market share in the specialty enzymes market due to several key
factors. The region is home to a robust pharmaceutical and
biotechnology industry, characterized by significant investments in
research and development. This investment landscape fosters
innovation, leading to the development of advanced enzyme-based
solutions. For instance, companies like Codexis, Inc. (US), are at
the forefront of enzyme engineering, continuously developing new
enzymes for pharmaceutical and industrial applications.
Moreover, the presence of well-established healthcare
infrastructure and a high demand for diagnostic tools contribute to
the market's growth. Specialty enzymes are crucial in various
diagnostic applications, including ELISA (Enzyme-Linked
Immunosorbent Assay) tests, which are widely used in medical
diagnostics. The increasing prevalence of chronic diseases such as
cancer and diabetes in North
America drives the demand for these advanced diagnostic
tools, further propelling the specialty enzymes market.
In addition, North America
benefits from favorable regulatory frameworks that support the
biotechnology sector. Agencies like the FDA (Food and Drug
Administration) ensure the safety and efficacy of enzyme-based
products, facilitating their adoption in medical and industrial
applications.
Key players in this market include BRAIN Biotech AG
(Germany), Novozymes A/S
(Denmark), Codexis, Inc. (US),
Sanofi (France), Merck KGaA
(Germany), Dyadic International
Inc (US), Advanced Enzyme Technologies (India), Amano Enzyme Inc (Japan), F. Hoffmann-La Roche Ltd (Switzerland), New England Biolabs (US), BBI
Solutions (UK), Creative Enzymes (US), Bioseutica (Netherland),
and SEKISUI Diagnostics (US).
Get 10% Free Customization on this Report:
https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=21682828
Browse Adjacent Reports @ Food and Beverage Market
Research Reports & Consulting
Related Reports:
Industrial Enzymes Market by Type (Carbohydrases,
Proteases, Lipases, Polymerases & Nucleases), Application (Food
& Beverages, Bioethanol, Feed, Detergents, Wastewater, Soil,
and Oil Treatment), Source, Formulation and Region - Global
Forecast to 2028
Food Enzymes Market by Type (Carbohydrases, Proteases,
Lipases, Polymerases & Nucleases), Source, Application (Food
& Beverages), Formulation, and Region (North America, Europe, Asia
Pacific, and South America)
- Global Forecast to 2026
Feed Enzymes Market by Type (Phytase, Carbohydrase, and
Protease), Livestock (Poultry, Swine, Ruminants, and Aquatic
Animals), Source (Microorganism, Plant, and Animal), Form (Dry and
Liquid), and Region - Global Forecast to 2025
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's
best management consulting firms by Forbes, as per their recent
report.
MarketsandMarkets™ is a blue ocean alternative in growth
consulting and program management, leveraging a man-machine
offering to drive supernormal growth for progressive organizations
in the B2B space. We have the widest lens on emerging technologies,
making us proficient in co-creating supernormal growth for
clients.
Earlier this year, we made a formal transformation into one of
America's best management consulting firms as per a survey
conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are
substituting existing revenue streams in this decade alone. We work
with clients on growth programs, helping them monetize this
$25 trillion opportunity through our
service lines - TAM Expansion, Go-to-Market (GTM) Strategy to
Execution, Market Share Gain, Account Enablement, and Thought
Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several
Forbes Global 2000 B2B companies - helping them stay relevant in a
disruptive ecosystem. Our insights and strategies are molded by our
industry experts, cutting-edge AI-powered Market Intelligence
Cloud, and years of research. The KnowledgeStore™ (our Market
Intelligence Cloud) integrates our research, facilitates an
analysis of interconnections through a set of applications, helping
clients look at the entire ecosystem and understand the revenue
shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or
follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan
Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight:
https://www.marketsandmarkets.com/ResearchInsight/specialty-enzymes-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source:
https://www.marketsandmarkets.com/PressReleases/specialty-enzymes.asp
Logo :
https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/specialty-enzymes-market-worth-9-2-billion-by-2029--exclusive-report-by-marketsandmarkets-302188702.html